These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9723625)
1. Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant Study. Davey PJ; Schulz M; Gliksman M; Dobson M; Aristides M; Stephens NG Am J Cardiol; 1998 Aug; 82(4):414-7. PubMed ID: 9723625 [TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Stephens NG; Parsons A; Schofield PM; Kelly F; Cheeseman K; Mitchinson MJ Lancet; 1996 Mar; 347(9004):781-6. PubMed ID: 8622332 [TBL] [Abstract][Full Text] [Related]
3. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451 [TBL] [Abstract][Full Text] [Related]
4. [Vitamin E treatment of patients with coronary disease (Cambridge Heart Antioxidant Study--CHAOS)]. Mörike EM Dtsch Med Wochenschr; 1996 May; 121(21):A9. PubMed ID: 8646973 [No Abstract] [Full Text] [Related]
5. Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy. Brown RE; Henderson RA; Koster D; Hutton J; Simoons ML Eur Heart J; 2002 Jan; 23(1):50-8. PubMed ID: 11741362 [TBL] [Abstract][Full Text] [Related]
6. Integrating cost-effectiveness evidence into clinical practice guidelines in Australia for acute myocardial infarction. Antioch KM; Jennings G; Botti M; Chapman R; Wulfsohn V Eur J Health Econ; 2002; 3(1):26-39. PubMed ID: 15609115 [TBL] [Abstract][Full Text] [Related]
7. Gemfibrozil cost-benefit study. Targeting subgroups for effective hyperlipidaemia drug therapy. Sarma S; Fifer SK Drugs; 1990; 40 Suppl 1():42-52. PubMed ID: 2127008 [TBL] [Abstract][Full Text] [Related]
8. Mortality in the CHAOS trial. Cambridge Heart Antioxidant Study. Ness A; Smith GD Lancet; 1999 Mar; 353(9157):1017-8. PubMed ID: 10459945 [No Abstract] [Full Text] [Related]
9. Comprehensive cardiac rehabilitation: is it cost-effective? Oldridge NB Eur Heart J; 1998 Nov; 19 Suppl O():O42-50. PubMed ID: 9857950 [TBL] [Abstract][Full Text] [Related]
10. A concise review of the cost-effectiveness of coronary heart disease prevention. Brown AI; Garber AM Med Clin North Am; 2000 Jan; 84(1):279-97, xi. PubMed ID: 10685140 [TBL] [Abstract][Full Text] [Related]
11. From Science to Finance-A Tool for Deriving Economic Implications from the Results of Dietary Supplement Clinical Studies. Shanahan CJ; de Lorimier R J Diet Suppl; 2016; 13(1):16-34. PubMed ID: 25166888 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Mahoney EM; Wang K; Arnold SV; Proskorovsky I; Wiviott S; Antman E; Braunwald E; Cohen DJ Circulation; 2010 Jan; 121(1):71-9. PubMed ID: 20026770 [TBL] [Abstract][Full Text] [Related]
13. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Heart Protection Study Collaborative Group Lancet; 2002 Jul; 360(9326):23-33. PubMed ID: 12114037 [TBL] [Abstract][Full Text] [Related]
14. The role of vitamin E in the prevention of heart disease. Emmert DH; Kirchner JT Arch Fam Med; 1999; 8(6):537-42. PubMed ID: 10575394 [TBL] [Abstract][Full Text] [Related]
15. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain. Gómez-Gerique JA; Casciano R; Stern L; Rejas J Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of vitamin D supplementation and exercise in preventing injurious falls among older home-dwelling women: findings from an RCT. Patil R; Kolu P; Raitanen J; Valvanne J; Kannus P; Karinkanta S; Sievänen H; Uusi-Rasi K Osteoporos Int; 2016 Jan; 27(1):193-201. PubMed ID: 26205890 [TBL] [Abstract][Full Text] [Related]
17. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. Weintraub WS; Mahoney EM; Lamy A; Culler S; Yuan Y; Caro J; Gabriel S; Yusuf S; J Am Coll Cardiol; 2005 Mar; 45(6):838-45. PubMed ID: 15766816 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. Bakhai A; Stone GW; Grines CL; Murphy SA; Githiora L; Berezin RH; Cox DA; Stuckey T; Griffin JJ; Tcheng JE; Cohen DJ; Circulation; 2003 Dec; 108(23):2857-63. PubMed ID: 14610016 [TBL] [Abstract][Full Text] [Related]
19. The value of coronary heart disease care for the elderly: 1987-2002. Rosen AB; Cutler DM; Norton DM; Hu HM; Vijan S Health Aff (Millwood); 2007; 26(1):111-23. PubMed ID: 17211020 [TBL] [Abstract][Full Text] [Related]